FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Ascend Laboratories Ibuprofen and Famotidine Tablets 800mg/26 Recall

Ibuprofen and Famotidine Tablets 800mg/26

Ascend Laboratories, LLC · Parsippany, NJ

Risk level
Class II
Reported by FDA
Jan 24, 2024
Recall ID
D-0237-2024
Check your lot numberHow we source this data

Summary

Ascend Laboratories recalled Ibuprofen and Famotidine Tablets 800mg/26 starting Dec 29, 2023. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0237-2024 on Jan 24, 2024. Reason: Presence of Foreign Tablet/Capsule: A stray Rasagiline Mesylate 1 mg tablet was discovered in an unopened bottle of Ibuprofen and Famotidine. Status: Ongoing.

Why it was recalled

Presence of Foreign Tablet/Capsule: A stray Rasagiline Mesylate 1 mg tablet was discovered in an unopened bottle of Ibuprofen and Famotidine.

Product description

Ibuprofen and Famotidine Tablets 800mg/26.6mg, Rx Only, 90 Tablets per Bottle, manufactured by: Alkem Laboratories Ltd., INDIA, Distributed by: Ascend Laboratories, LLC., Parsippany, NJ 07054, NDC 67877-626-90

Lot numbers, UPCs & expiration codes

23140190, Exp. Date 12/31/2024

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0237-2024
Classification
Class II
Status
Ongoing
Recall initiated
Dec 29, 2023
FDA report date
Jan 24, 2024
Quantity
3,288 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Ascend Laboratories, LLC

Original FDA data

Every field from FDA enforcement report D-0237-2024, exactly as published.

Show all FDA fields
City
Parsippany
State
NJ
Status
Ongoing
Country
United States
Event ID
93701
Address
339 Jefferson Rd Ste 101
Code information
23140190, Exp. Date 12/31/2024
Postal code
07054-3707
Report date
Jan 24, 2024
Product type
Drugs
Recall number
D-0237-2024
Classification
Class II
Recalling firm
Ascend Laboratories, LLC
Product quantity
3,288 bottles
Reason for recall
Presence of Foreign Tablet/Capsule: A stray Rasagiline Mesylate 1 mg tablet was discovered in an unopened bottle of Ibuprofen and Famotidine.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Ibuprofen and Famotidine Tablets 800mg/26.6mg, Rx Only, 90 Tablets per Bottle, manufactured by: Alkem Laboratories Ltd., INDIA, Distributed by: Ascend Laboratories, LLC., Parsippany, NJ 07054, NDC 67877-626-90
Distribution pattern
Nationwide
Recall initiation date
Dec 29, 2023
Initial firm notification
Letter
Center classification date
Jan 17, 2024

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0237-2024, published Jan 24, 2024. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls